跳至主要内容
临床试验/NCT01800890
NCT01800890已完成不适用

Investigating the Safety and Performance of New 2-piece Ostomy Product Concept Compared With SenSura Click in Subjects With Ileostomy

Coloplast A/S1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2013年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Coloplast A/S
入组人数
31
试验地点
1
主要终点
Degree of Leakage

研究概览

简要总结

The aim of the current clinical investigation is to evaluate the performance and safety of new 2-piece ostomy product concepts.

详细描述

The new products have been developed to reduce the degree of leakage and other problems related to ostomy appliances in people with a stoma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Have given written informed consent and signed letter of authority form.
  • •Be at least 18 years of age and have full legal capacity.
  • •Be able to handle the appliances themselves
  • •Have an ileostomy with a diameter between 15 and 40 mm.
  • •Have had their ostomy for at least three months.
  • •Use minimum 1 baseplate every third day.
  • •Currently use 2-piece flat mechanical coupling product with open bag and a coupling size in the inter val of 43-55mm (both extremes included)
  • •Must be able to use custom cut product
  • •Accept to test three 2-piece products within the study.
  • •Negative result of a pregnancy test for women of childbearing age.

排除标准

  • •Use irrigation during the study (flush the stoma with water).
  • •Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
  • •Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area.
  • •Are pregnant or breastfeeding.
  • •Participating in other interventional clinical investigations or have previously participated in this investigation.
  • •More than three days wear time as usual change pattern.
  • •Currently using ostomy belt
  • •Currently using extended wear product (Sensura Xpro, Assura TERA, Dansac NovaLife X3, Hollister Flextend, Convatec Durahesive)
  • •Have a loop ileostomy
  • •Known hypersensitivity towards any of the test products
  • •Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)

研究组 & 干预措施

Treatment sequence 1

Other

Subjects randomised to Treatment sequence 1 will test three different products:

  1. Coloplast A
  2. Coloplast B
  3. SenSura Click

The subjects test the three test products in a randomized order: ABS; BSA, SAB

干预措施: Coloplast A (Device)

Treatment sequence 1

Other

Subjects randomised to Treatment sequence 1 will test three different products:

  1. Coloplast A
  2. Coloplast B
  3. SenSura Click

The subjects test the three test products in a randomized order: ABS; BSA, SAB

干预措施: Coloplast B (Device)

Treatment sequence 1

Other

Subjects randomised to Treatment sequence 1 will test three different products:

  1. Coloplast A
  2. Coloplast B
  3. SenSura Click

The subjects test the three test products in a randomized order: ABS; BSA, SAB

干预措施: SenSura Click (Device)

Treatment sequence 2

Experimental

Subjects randomised to Treatment sequence 2 will test three different products:

  1. Coloplast C (C)
  2. Coloplast B (B)
  3. SenSura Click (S)

The subjects test the three test products in a randomized order: CBS; BSC, SCB

干预措施: Coloplast B (Device)

Treatment sequence 2

Experimental

Subjects randomised to Treatment sequence 2 will test three different products:

  1. Coloplast C (C)
  2. Coloplast B (B)
  3. SenSura Click (S)

The subjects test the three test products in a randomized order: CBS; BSC, SCB

干预措施: Coloplast C (Device)

Treatment sequence 2

Experimental

Subjects randomised to Treatment sequence 2 will test three different products:

  1. Coloplast C (C)
  2. Coloplast B (B)
  3. SenSura Click (S)

The subjects test the three test products in a randomized order: CBS; BSC, SCB

干预措施: SenSura Click (Device)

Treatment sequence 3

Experimental

Subjects randomised to Treatment sequence 3 will test three different products:

  1. Coloplast A (A)
  2. Coloplast C (C)
  3. SenSura Click (S)

The subjects test the three test products in a randomized order: ACS; CSA, SAC

干预措施: Coloplast A (Device)

Treatment sequence 3

Experimental

Subjects randomised to Treatment sequence 3 will test three different products:

  1. Coloplast A (A)
  2. Coloplast C (C)
  3. SenSura Click (S)

The subjects test the three test products in a randomized order: ACS; CSA, SAC

干预措施: Coloplast C (Device)

Treatment sequence 3

Experimental

Subjects randomised to Treatment sequence 3 will test three different products:

  1. Coloplast A (A)
  2. Coloplast C (C)
  3. SenSura Click (S)

The subjects test the three test products in a randomized order: ACS; CSA, SAC

干预措施: SenSura Click (Device)

结局指标

主要结局

Degree of Leakage

时间窗: 10 days

The degree of leakage is assessed using a 4 point leakage scale developed by Coloplast A/S. The 4-point leakage scale has four choices 1. No leakage 2. Starting to leakage 3. Leakage 4. Sudden leakage Leakage was assessed at every baseplate change

次要结局

未报告次要终点

研究者

发起方
Coloplast A/S
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验